Thomas Pohl

Thomas Pohl, Ph.D. joined Novartis in 2015 and currently holds the position of a Director Analytical Development within the Technical Research and Development unit Biologics. He is leading a team responsible for the physico-chemical characterization of biopharmaceuticals from early to late stage development at the Basel site in Switzerland. Before joining Novartis, he had been working for a start-up company in Munich, Germany being responsible for the various aspects of the technical development of biopharmaceutical drug candidates.